meddevicedb.com FDA Device Reference

HEMAGEN CRP 150 KIT (EIA METHOD)

K960324 Class II Traditional
Decision Date
1996-03-12
Sponsor / Applicant
Hemagen Diagnostics, Inc.

Technical Specification

510(k) Submission ID K960324
Product Code DCK
Medical Specialty / Panel Immunology
Regulation Citation 21 CFR 866.5270
Decision Date 1996-03-12
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

HEMAGEN CRP 150 KIT (EIA METHOD) received FDA 510(k) clearance under submission number K960324, sponsored by Hemagen Diagnostics, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1996-03-12.

Classification & Regulation

This clearance is catalogued under FDA product code DCK and 21 CFR 866.5270, within the Immunology review panel as a Class II device.